Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia. (2023)
Attributed to:
COVID-19 Immunity - National Core Study (IMM-NCS)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2023-077946
PubMed Identifier: 37770269
Publication URI: http://europepmc.org/abstract/MED/37770269
Type: Journal Article/Review
Volume: 13
Parent Publication: BMJ open
Issue: 9
ISSN: 2044-6055